Sign In
Buy WGS
$53.02
-0.110 (-0.207%)
At Close: Jun 03, 2026
INVESTOR ALERT: Investigation of GeneDx Holdings Corp. (WGS) announced by Holzer & Holzer, LLC
03:04pm, Wednesday, 06'th May 2026
ATLANTA, May 06, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) complied with federal securities laws. O
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GeneDx Holdings Co
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
10:12am, Wednesday, 06'th May 2026
One of these stocks plummeted 49% on Tuesday.
GeneDx Holdings Corp. (WGS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
09:00am, Wednesday, 06'th May 2026
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) investors concerning t
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating GeneDX Holdings Corp. (NYSE: WGS) for potential securities law violations. Investors who have lost money in their GeneDX Holdi
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS) on behalf of investors concerning
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GeneDx Holdings Corp.
02:58pm, Tuesday, 05'th May 2026
MILWAUKEE, May 5, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against GeneDx (Nasdaq: WGS). The investigation results from inaccurate statements GeneDx may have ma
Why GeneDX Stock Is Plummeting Today
11:03am, Tuesday, 05'th May 2026
GeneDX's latest quarterly report arrived with a lot of bad news for investors.
The 'Alarming' Results That Caused GeneDx Stock To Plummet 45%
09:35am, Tuesday, 05'th May 2026
GeneDx stock crashed Tuesday on what one analyst called its "alarming" first-quarter sales miss, leading to a guidance cut for the year.
SAN DIEGO, May 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of GeneDx Holdings Corp. (NASDAQ: WGS). The investigation focuses on GeneDx's
GeneDx Holdings Corp. (WGS) Q1 2026 Earnings Call Transcript
08:13pm, Monday, 04'th May 2026
GeneDx Holdings Corp. (WGS) Q1 2026 Earnings Call Transcript
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue Estimates
06:56pm, Monday, 04'th May 2026
GeneDx Holdings Corp. (WGS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to earnings of $0.28 per share a year ago.
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
04:05pm, Monday, 04'th May 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx reported first quarter financial results and business highlights, including 34% year-over-year volume growth in exome and genome testing.
Alger Small Cap Growth Fund Q1 2026 Portfolio Update
03:03pm, Wednesday, 29'th Apr 2026
Class A shares of the Alger Small Cap Growth Fund underperformed the Russell 2000 Growth Index during the first quarter of 2026. RBC Bearings, Nebius Group, and Modine Manufacturing Company were among
Will Robust Exome and Genome Revenues Lift GeneDx's Q1 Earnings?
09:20am, Monday, 27'th Apr 2026
GeneDx heads into Q1 earnings results with strong exome and genome momentum, supported by expanding adoption and a growing rare-disease data advantage.
